Search results
29 gru 2021 · PPS should be differentiated from isolated pericardial or pleural effusion seen after cardiac surgery, and specific diagnostic criteria exist. 40 Colchicine should be considered for PPS treatment according to ESC guidelines (class IIa recommendation, level of evidence B) using the pericarditis treatment regimens. 6 The role of colchicine in the ...
- Colchicine’s Role in Cardiovascular Disease Management
The LoDoCo2 trial (Low-Dose Colchicine-2) and COLCOT...
- Colchicine’s Role in Cardiovascular Disease Management
Colchicine is an old anti-inflammatory drug that has shown substantial cardiovascular benefits in recent trials. We systematically reviewed cardiovascular benefits and harms of colchicine in any population and specifically in patients with high cardiovascular risk.
21 mar 2024 · The LoDoCo2 trial (Low-Dose Colchicine-2) and COLCOT (Colchicine Cardiovascular Outcomes Trial) demonstrated the efficacy of colchicine in lowering the risk of major adverse cardiovascular events in people with stable coronary artery disease (LoDoCo2) and recent myocardial infarction (COLCOT).
Generic Name (S): colchicine (cardiac) Uses. Side Effects. Precautions. Interactions. Overdose. Images. Reviews (0) Uses. Colchicine is used by people with heart disease or people who...
10 kwi 2024 · Article history. PDF. Split View. Cite. Permissions. Share. Abstract. Low-dose colchicine (0.5 mg daily) is now FDA-approved for secondary prevention in patients with coronary disease and will be increasingly prescribed in clinical practice.
31 sie 2020 · Evidence from a recent trial has shown that the antiinflammatory effects of colchicine reduce the risk of cardiovascular events in patients with recent myocardial infarction, but evidence of...
1 lut 2024 · Colchicine is also used to reduce the risk of heart attack, stroke, certain types of heart procedures, and cardiovascular death in patients with atherosclerosis (known buildup of plaque inside the arteries) or with multiple cardiovascular risk factors.
